Table 2.
Clinical characteristics and laboratory findings in 48 patients with allergic bronchopulmonary aspergillosis
| Parameter | Value |
|---|---|
| Age (years) ±SD | 45.43±14.89 |
| Sex ratio M:F | 30:18 |
| Cough | 48 (100%) |
| Expectoration | 26 (54.16%) |
| Hemoptysis | 2 (4.16%) |
| History of ATT | 9 (18.75%) |
| Smokers | 7 (14.58%) |
| Severity of Asthma (GINA classification) | |
| Mild intermittent | 20 (41.6%) |
| Mild persistent | 21 (43.75%) |
| Moderate persistent | 6 (12.50%) |
| Severe persistent | 1 (2.08%) |
| AEC (SD) | 797.20±1160.06 |
| AEC >500 | 17 (35.42%) |
| IgE (IU/mL) | 3122.83±3374.73 |
| IgE >1000 IU/mL | 37 (77.08%) |
| Specific IgE (kUA/L) | 10.25±20.26 |
SD: Standard Deviation, ATT: Anti-tubercular treatment, GINA: Global Initiative for Asthma, AEC: Absolute Eosinophil Count, IgE: Immunoglobulin E, IU/mL: International Units per millilitre, kUA/L: Kilo units of allergen per litre